00000000nam 2200000za 4500
0019.847173
003CaOODSP
00520221107153400
007cr |||||||||||
008180223s2017    quc     o    f00| 0 eng d
020 |a978-0-660-23863-0
040 |aCaOODSP|beng
043 |an-cn---
0861 |aEn14-297/2017E-PDF
24500|aScreening assessment |h[electronic resource] : |bbenzenesulfonamide, 2-methyl : Chemical Abstracts Service registry number 88-19-7 / |cEnvironment and Climate Change Canada, Health Canada.
260 |a[Gatineau, QC] : |bEnvironment and Climate Change Canada, |c2017.
300 |aiii, 18 p.
500 |aIssued also in French under title: Évaluation préalable : toluène-2-sulfonamide : numéro de registre du Chemical Abstracts Service 88-19-7.
500 |aCover title.
500 |a"December 2017."
500 |aImperfect copy: verso of cover wanting.
504 |aIncludes bibliographical references.
520 |a"Pursuant to section 68 of the Canadian Environmental Protection Act, 1999 (CEPA) (Canada 1999), the Minister of the Environment and the Minister of Health have conducted a screening assessment of benzenesulfonamide, 2-methyl (2-MBS) to determine whether this substance presents or may present a risk to the environment or to human health. This substance was considered a priority on the basis of other human health concerns. This screening assessment includes consideration of information on chemical properties, environmental fate, hazards, uses and exposures, including additional information submitted by stakeholders. Relevant data were identified up to October 2016. Empirical data from key studies as well as some results from models were used to reach the conclusions”--Introd., p. 1.
69207|2gccst|aChemicals
69207|2gccst|aEnvironmental impact
69207|2gccst|aHealth impact
69207|2gccst|aRisk management
693 4|aSulfonamides
7101 |aCanada. |bHealth Canada.
7101 |aCanada. |bEnvironment and Climate Change Canada.
77508|tÉvaluation préalable |w(CaOODSP)9.847174
85640|qPDF|s144 KB|uhttps://publications.gc.ca/collections/collection_2018/eccc/En14-297-2017-eng.pdf